biotech pharmaceutical news
Man-made proteins. You may have never heard of them, but you will.
They are set to become huge change agents in the high-tech world of the very near future.
Some of you may have already heard the recent news that doctors believe they can use these compounds to help fight the flu.
The major media was all over this angle. And no doubt, it's an important advance.
In the U.S. alone, 200,000 people get so sick from the flu they have to go to the hospital each year. U.S. health officials say as many as 50,000 people die.
The version of synthetic protein that can help boost your immune system to fight the flu is called EP67.
Earlier this month, a team from San Diego State University and the University of Nebraska Medical Center tested the substance on mice - with great results.
In a paper that ran in the journal PLoS One, they said mice given a lethal dose of the flu survived after getting an injection of the protein. What's more, it could be used to guard against other diseases, as well.
"Since EP67 works by stimulating local innate immunity, it should prove effective against viral, bacterial and fungal diseases," said Joy Phillips, the study's lead author. She noted said they still need to test the protein on larger mammals and humans.
There is a catch - you have to get a dose of EP67 within 24 hours of exposure to the bug for it to be effective.
Still, clearly, synthetic proteins could have a huge impact on public health.
Yet I believe the media missed the real story.
With a hot new field of science known as "directed evolution," scientists will do far more than treat disease.
They may just redesign our digital universe.
How Directed Evolution WorksThe idea is pretty simple. Genetic engineers apply evolutionary design methods to biological systems.
In this way, they seek to "evolve" proteins and organisms that have unique aspects not found in nature. They can have useful applications in medicine, alternative energy, and the like.
Making sense of this new advance requires us to take a look at proteins from a unique point of view.
To continue reading, please click here...
This Biotech Startup Just Scored a Key Cancer Breakthrough
Don't worry if you've never heard of Robert Langer. Few investors have.
But 20 years from now, when some enterprising author writes the book about how the United States finally found a cure for cancer, you can bet that Langer will be there, front and center, in the table of contents, or maybe even on the cover.
Today Langer is a distinguished professor at MIT, in chemical and biomedical engineering. More importantly for investors like us, he is the co-founder of a hot biotech startup that just reported a key cancer breakthrough.
It's called BIND Biosciences. And it isn't just on an IPO track.
It's one of the companies I refer to when I say technology can save America. Thanks to this nation's innovative thinkers and savvy entrepreneurs, just like Langer, this country leads the world in high-tech breakthroughs - the kind that reshape lives and histories. And that's what makes me truly believe that The Land of Opportunity is bound to come out ahead in the long run.
So if you want to make big money in the Era of Radical Change, you can forget about the global debt crisis. Ditto Washington's antics. Same goes for monthly jobs reports and even the market's ups and downs.
You need to keep an eye on guys like Bob Langer.
His Team Has Given Millions New Reason for HopeRight now 12 million Americans are suffering from some form of cancer; the disease will kill one-third of them outright. In the next 24 hours, nearly 1,500 cancer patients will die. Odds are, several people will have passed away by the time you read this report.
Many of you will relate to this on a personal level. I know I do. Cancer killed my maternal grandmother and two of my friends.
Yet today, finally, after many billions of dollars funneled into cancer research over the decades, I believe we have passed the "tipping point" in our long battle against this deadly disease. I predict that within a decade we will cut the number of cancer deaths in half.
Not only will sharp biotech investors (like us) profit along the way, the nation as a whole will get a tremendous payoff when that happens. After all, cancer costs the U.S. roughly $225 billion a year in health-care bills and lost wages.
So, the Langer team's breakthrough has much to offer America, at a time when many people fear that China is getting ready to have us for lunch. Well, let me tell you this. You won't see this kind of innovation coming out of China any time soon.
Here's How They Did ItAs it turns out, Langer's team used very small - but very mighty - weapons to fight the cancer war.
To continue reading, please click here...